Showing 2071-2080 of 20409 results for "".
Improving the Safety of Generic Pharmaceuticals
https://reachmd.com/programs/clinicians-roundtable/improving-the-safety-of-generic-pharmaceuticals/2899/Some physicians are still skittish about prescribing generic drugs, but the manufacturers of these less expensive medicines say they are increasingly important and there is less need to worry about their quality and safety than ever before. Kathleen Jaeger, president and CEO of the Generic PharmaceuCVD Risk Factors and Cognitive Impairment
https://reachmd.com/programs/lipid-luminations/cvd-risk-factors-and-cognitive-impairment/2803/Dr. Larry Kaskel welcomes Dr. David T. Nash to Lipid Luminations. Dr. Nash is with Syracuse Preventive Cardiology and will discuss how lipid abnormalities and genetic markers are associated with an increased risk for cardiovascular disease and cognitive impairment. He will also speak about how patieInsomniac: A Doctor's Personal Journey
https://reachmd.com/programs/clinicians-roundtable/insomniac/2798/What is it like to be a patient with insomnia? To be told it’s your fault, to just rela, or to take any one or combination of a myriad of medications? Dr. Gayle Greene weaves together her personal experience with insomnia and the latest sleep science from her book Insomniac with host Dr. Leslie LundTight Glycemic Control for the Critically Ill
https://reachmd.com/programs/focus-on-pharmacy/tight-glycemic-control-for-the-critically-ill/2771/When attempting to control blood sugar levels in critically ill patients, how far should we go? Host Dr. Charles Turck probes this question and more with Dr. Brian Smith, director of education in clinical services of the pharmacy department of the University of Massachussetts (UMass) Memorial MedicaBRCA Gene Mutations: Health Information & Families
https://reachmd.com/programs/clinicians-roundtable/brca-gene-mutations-health-information-families/2763/Dr. Mary Daly, oncologist, PhD epidemiologist, Director of the Cancer Prevention and Control Program, and Senior Vice President for Population Science at the Fox Chase Cancer Center speaks with your host, Dr. Gary Kohn, on cancer prevention, the implications of BRCA 1&2 regarding risk of breastIntern: A Doctor's Initiation, Part 2
https://reachmd.com/programs/clinicians-roundtable/intern-a-doctors-initiation-part-2/2762/Dr. Gary Kohn speaks with Dr. Sandeep Jauhar, physicist, cardiologist, medical writer, and director of the Heart Failure Program at the Long Island Jewish Medical Center in New York regarding his book, Intern: A doctor's initiation.Intern: A Doctor's Initiation, Part 1
https://reachmd.com/programs/clinicians-roundtable/intern-a-doctors-initiation-part-1/2761/Dr. Sandeep Jauhar, physicist, cardiologist, medical writer, and Director of the Heart Failure Program at the Long Island Jewish Medical Center in New York City speaks with your host, Dr. Gary Kohn about the transitional period of internship in his book, "Intern: A Doctor's Initiation". Dr. Jauhar rVaccinating for Adult Shingles: New Initiatives
https://reachmd.com/programs/clinicians-roundtable/vaccinating-for-adult-shingles-new-initiatives/2727/A vaccine for adult Shingles was approved in 2006 by the FDA and is in use today. Yet delivery of this vaccination has not been as widespread as it could and should be. With this in mind, many hospitals and clinics are working to improve on their current approach to its distribution; at some healthThe Efficacy of the 2007-2008 Influenza Vaccines
https://reachmd.com/programs/clinicians-roundtable/the-efficacy-of-the-2007-2008-influenza-vaccines/2724/Why has this year's flu season seemed more severe than those in the past? Are the vaccines working? Are influenza strains more difficult to predict? In addressing this year's peculiar flu season, host Dr. Bruce Bloom speaks with Dr. Tony Fiore, a vaccination and immunization expert from the CDC's NaThe Basics Of Contrast-Induced Nephropathy
https://reachmd.com/programs/clinicians-roundtable/the-basics-of-contrast-induced-nephropathy/2701/Dr. Rudnick reviews the reasons for the rising incidence of contrast-induced renal problems. He outlines the risk factors for "CIN" - both related to procedures and patients - and then comments on the clinical significance of this growing issue.